Practical aspects of using Witepsol H15 in pharmaceutical compounding

New excipients increase new possibilities of the modifications in the composition of a compounded drugs. One of the examples is a Witepsol H15 suppository base registered in 2018 as an alternative to the previously used cocoa oil. The use of Witepsol H15 requires the determination of the replacement...

Full description

Bibliographic Details
Main Authors: Aldona Maciejewska, Krzysztof Niwiński, Kamil Kornaus, Paweł Rutkowski
Format: Article
Language:Polish
Published: Polish Pharmaceutical Society 2023-11-01
Series:Farmacja Polska
Subjects:
Online Access:https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2023%2F7%2F05_SZ_Praktyczne_aspekty_Witepsol_H15_n.pdf
_version_ 1797373825789198336
author Aldona Maciejewska
Krzysztof Niwiński
Kamil Kornaus
Paweł Rutkowski
author_facet Aldona Maciejewska
Krzysztof Niwiński
Kamil Kornaus
Paweł Rutkowski
author_sort Aldona Maciejewska
collection DOAJ
description New excipients increase new possibilities of the modifications in the composition of a compounded drugs. One of the examples is a Witepsol H15 suppository base registered in 2018 as an alternative to the previously used cocoa oil. The use of Witepsol H15 requires the determination of the replacement factors for active substances and excipients to calculate the optimal amount of this suppository base to prepare a certain number of suppositories. The classical method, which has been used so far, is based on the measurements of the mass of the suppositories with and without API, and the determination of the replacement factor using a calculation formula. Taking into account the differences between replacement coefficients resulting for example from a type and concentration of the active substance or excipient, the method of mixing and its parameters, it is reasonable to introduce an alternative calculation method based on the density measurements determined pycnometrically. Density measurements of excipients, APIs and selected medicinal products were carried out using the helium pycnometry method. Based on the ratio between density of the substrate to the API/excipient, the replacement coefficients were calculated. In total, two suppository bases (Witepsol H15 and Cacao oleum), 17 active substances, 2 excipients and 8 medicinal products were tested. The results were presented in tables, compared with available literature data and percentage differences were calculated. In order to complete the practical information regarding use of Witepsol H15, the numerous test on the functional properties of the base were carried out, including: volume contraction, sensitivity to process factors, thermal changes during heating and cooling. The ability to reduce the volume of the base during solidification has been confirmed, which allows an easy withdrawal of the suppository from the mold before application. The average contraction for Witepsol H15 is 3.23%, which is about 3 times higher compared to cocoa oil (1.13%). An analysis of the behavior during cooling of Witepsol H15 heated to different temperatures, was carried out and it was found that the overheated base shows stepped thermal changes profile while solidifying. The profile of temperature changes of properly liquefied base is predictable and does not show dynamic changes. Based on the DSC data, the liquid fraction content of Witepsol H15 was calculated. The base heated previously to 45 °C contains more liquid components than the unheated base. A practical implication is the recommendation to not overheat the base in order to obtain proper liquefaction of the suppository mass, easy filling of molds and limitation in the sedimentation of ingredients in suppositories. The results of performed studies confirm the usefulness of helium pycnometry to measure the density of substances and suppository bases, and to determine on their basis the displacement coefficients of active substances/excipients not included in the compendia so far. The helium pycnometry method enables the calculation of the displacement coefficient in the objective manner, independent of many factors, such as: base variability, preparation method, mixing parameters, content of API and excipients, size and load of the mixing container, conditions of solidification of the suppository mass. The replacement factors obtained in this way may be helpful in compounding practice. With the correct selection of mixing parameters, they lead to the obtainment of optimal amount of liquefied suppository mass necessary to fill the molds.
first_indexed 2024-03-08T18:56:02Z
format Article
id doaj.art-a82d1958c795440baebadc086155f514
institution Directory Open Access Journal
issn 0014-8261
language Polish
last_indexed 2024-03-08T18:56:02Z
publishDate 2023-11-01
publisher Polish Pharmaceutical Society
record_format Article
series Farmacja Polska
spelling doaj.art-a82d1958c795440baebadc086155f5142023-12-28T12:27:53ZpolPolish Pharmaceutical SocietyFarmacja Polska0014-82612023-11-0179742142910.32383/farmpol/174889174889Practical aspects of using Witepsol H15 in pharmaceutical compoundingAldona Maciejewska0https://orcid.org/0000-0003-0172-4038Krzysztof Niwiński1https://orcid.org/0000-0001-7702-9790Kamil Kornaus2https://orcid.org/0000-0001-5762-7742Paweł Rutkowski3https://orcid.org/0000-0001-6181-5981Katedra Technologii Postaci Leku i Biofarmacji, Collegium Medicum Uniwersytet Jagielloński, PolskaKatedra Technologii Postaci Leku i Biofarmacji, Collegium Medicum Uniwersytet Jagielloński, PolskaKatedra Ceramiki i Materiałów Ogniotrwałych, Akademia Górniczo-Hutnicza i. S. Staszica w Krakowie Wydział Inżynierii Materiałowej i Ceramiki, PolskaKatedra Ceramiki i Materiałów Ogniotrwałych, Akademia Górniczo-Hutnicza i. S. Staszica w Krakowie Wydział Inżynierii Materiałowej i Ceramiki, PolskaNew excipients increase new possibilities of the modifications in the composition of a compounded drugs. One of the examples is a Witepsol H15 suppository base registered in 2018 as an alternative to the previously used cocoa oil. The use of Witepsol H15 requires the determination of the replacement factors for active substances and excipients to calculate the optimal amount of this suppository base to prepare a certain number of suppositories. The classical method, which has been used so far, is based on the measurements of the mass of the suppositories with and without API, and the determination of the replacement factor using a calculation formula. Taking into account the differences between replacement coefficients resulting for example from a type and concentration of the active substance or excipient, the method of mixing and its parameters, it is reasonable to introduce an alternative calculation method based on the density measurements determined pycnometrically. Density measurements of excipients, APIs and selected medicinal products were carried out using the helium pycnometry method. Based on the ratio between density of the substrate to the API/excipient, the replacement coefficients were calculated. In total, two suppository bases (Witepsol H15 and Cacao oleum), 17 active substances, 2 excipients and 8 medicinal products were tested. The results were presented in tables, compared with available literature data and percentage differences were calculated. In order to complete the practical information regarding use of Witepsol H15, the numerous test on the functional properties of the base were carried out, including: volume contraction, sensitivity to process factors, thermal changes during heating and cooling. The ability to reduce the volume of the base during solidification has been confirmed, which allows an easy withdrawal of the suppository from the mold before application. The average contraction for Witepsol H15 is 3.23%, which is about 3 times higher compared to cocoa oil (1.13%). An analysis of the behavior during cooling of Witepsol H15 heated to different temperatures, was carried out and it was found that the overheated base shows stepped thermal changes profile while solidifying. The profile of temperature changes of properly liquefied base is predictable and does not show dynamic changes. Based on the DSC data, the liquid fraction content of Witepsol H15 was calculated. The base heated previously to 45 °C contains more liquid components than the unheated base. A practical implication is the recommendation to not overheat the base in order to obtain proper liquefaction of the suppository mass, easy filling of molds and limitation in the sedimentation of ingredients in suppositories. The results of performed studies confirm the usefulness of helium pycnometry to measure the density of substances and suppository bases, and to determine on their basis the displacement coefficients of active substances/excipients not included in the compendia so far. The helium pycnometry method enables the calculation of the displacement coefficient in the objective manner, independent of many factors, such as: base variability, preparation method, mixing parameters, content of API and excipients, size and load of the mixing container, conditions of solidification of the suppository mass. The replacement factors obtained in this way may be helpful in compounding practice. With the correct selection of mixing parameters, they lead to the obtainment of optimal amount of liquefied suppository mass necessary to fill the molds.https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2023%2F7%2F05_SZ_Praktyczne_aspekty_Witepsol_H15_n.pdfsuppository basewitepsol h15replacement factor
spellingShingle Aldona Maciejewska
Krzysztof Niwiński
Kamil Kornaus
Paweł Rutkowski
Practical aspects of using Witepsol H15 in pharmaceutical compounding
Farmacja Polska
suppository base
witepsol h15
replacement factor
title Practical aspects of using Witepsol H15 in pharmaceutical compounding
title_full Practical aspects of using Witepsol H15 in pharmaceutical compounding
title_fullStr Practical aspects of using Witepsol H15 in pharmaceutical compounding
title_full_unstemmed Practical aspects of using Witepsol H15 in pharmaceutical compounding
title_short Practical aspects of using Witepsol H15 in pharmaceutical compounding
title_sort practical aspects of using witepsol h15 in pharmaceutical compounding
topic suppository base
witepsol h15
replacement factor
url https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2023%2F7%2F05_SZ_Praktyczne_aspekty_Witepsol_H15_n.pdf
work_keys_str_mv AT aldonamaciejewska practicalaspectsofusingwitepsolh15inpharmaceuticalcompounding
AT krzysztofniwinski practicalaspectsofusingwitepsolh15inpharmaceuticalcompounding
AT kamilkornaus practicalaspectsofusingwitepsolh15inpharmaceuticalcompounding
AT pawełrutkowski practicalaspectsofusingwitepsolh15inpharmaceuticalcompounding